Steward Financial Group’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $0 | Buy |
+8
| New | – | ﹤0.01% | 1335 |
|
|
2023
Q2 | – | Sell |
-57
| Closed | – | – | 503 |
|
|
2023
Q1 | $0 | Buy |
57
+17
| +43% | – | ﹤0.01% | 727 |
|
|
2022
Q4 | $0 | Buy |
+40
| New | – | ﹤0.01% | 561 |
|
|
2022
Q3 | – | Sell |
-40
| Closed | – | – | 197 |
|
|
2022
Q2 | $0 | Buy |
+40
| New | – | ﹤0.01% | 985 |
|